Anemia in Breast Cancer Patients Undergoing Chemotherapy
Author Information
Author(s): Goldrick A. MD, Olivotto I.A. MD, Alexander C.S. CCHRA(C), Speers C.H. BA CCHRA(C), Barnett J. BSc (Pharm) MSc, Allan S.J. MD, Truong P.T. MDCM
Primary Institution: BC Cancer Agency
Hypothesis
What is the frequency and severity of anemia during adjuvant chemotherapy for breast cancer?
Conclusion
Anemia is common among breast cancer patients receiving chemotherapy, but discussions and interventions for anemia are infrequent.
Supporting Evidence
- 78% of patients had at least one hemoglobin reading <120 g/L.
- 54% of patients had at least one hemoglobin reading <110 g/L.
- 31% of patients had at least one hemoglobin reading <100 g/L.
- 14% of patients had at least one hemoglobin reading <90 g/L.
- Intervention rates increased as hemoglobin declined.
Takeaway
Many women getting treatment for breast cancer become anemic, but doctors often don't talk about it or help fix it.
Methodology
Retrospective electronic chart review of 702 patients who received adjuvant chemotherapy at four BC Cancer Agency centres.
Potential Biases
Potential underreporting of discussions and interventions for anemia in patient charts.
Limitations
The study did not record the magnitude of fatigue or quality of life effects, and some patients may not have been symptomatic.
Participant Demographics
Median age of participants was 51 years; 12% had a hemoglobin reading <120 g/L before chemotherapy.
Want to read the original?
Access the complete publication on the publisher's website